Home » Topics » Regulatory » Patents

Patents
RSS

Sagami reports novel antitumor agents

Jan. 27, 1997

Antithrombotics described by Terumo

Jan. 27, 1997

Sumitomo claims antiplatelet agents

Jan. 27, 1997

NK1 antagonists from Takeda

Jan. 27, 1997

Hoechst reports new Na+/K+-exchange inhibitors

Jan. 27, 1997

Therapeutically active PTH derivatives reported by Takeda

Jan. 27, 1997

FPTase inhibitors in early development at Merck & Co.

Jan. 27, 1997

Excitatory amino acid receptor ligands from Schering AG

Jan. 27, 1997

Improved fibrinogen antagonists from DuPont Merck

Jan. 27, 1997

Fujisawa investigates tachykinin antagonists

Jan. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...